| Product Code: ETC7548446 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Myasthenia Gravis Disease Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Myasthenia Gravis Disease Market Revenues & Volume, 2021 & 2031F |
3.3 India Myasthenia Gravis Disease Market - Industry Life Cycle |
3.4 India Myasthenia Gravis Disease Market - Porter's Five Forces |
3.5 India Myasthenia Gravis Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 India Myasthenia Gravis Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 India Myasthenia Gravis Disease Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 India Myasthenia Gravis Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 India Myasthenia Gravis Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Myasthenia Gravis Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of myasthenia gravis in India |
4.2.2 Rising healthcare expenditure and government initiatives to improve access to treatment |
4.2.3 Technological advancements in the development of new therapies for myasthenia gravis |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in rural areas of India |
4.3.2 High cost of treatment and lack of insurance coverage for myasthenia gravis patients |
4.3.3 Potential side effects and risks associated with current treatment options |
5 India Myasthenia Gravis Disease Market Trends |
6 India Myasthenia Gravis Disease Market, By Types |
6.1 India Myasthenia Gravis Disease Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 India Myasthenia Gravis Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 India Myasthenia Gravis Disease Market Revenues & Volume, By Edrophonium Test, 2021- 2031F |
6.1.4 India Myasthenia Gravis Disease Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.1.5 India Myasthenia Gravis Disease Market Revenues & Volume, By Repetitive Nerve Stimulation, 2021- 2031F |
6.1.6 India Myasthenia Gravis Disease Market Revenues & Volume, By Single-fiber electromyography (EMG), 2021- 2031F |
6.1.7 India Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Myasthenia Gravis Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 India Myasthenia Gravis Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 India Myasthenia Gravis Disease Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2.4 India Myasthenia Gravis Disease Market Revenues & Volume, By Immunosuppressants, 2021- 2031F |
6.2.5 India Myasthenia Gravis Disease Market Revenues & Volume, By Plasmapheresis, 2021- 2031F |
6.2.6 India Myasthenia Gravis Disease Market Revenues & Volume, By Autologous Hematopoietic Stem Cell Transplantation (HSCT), 2021- 2031F |
6.2.7 India Myasthenia Gravis Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 India Myasthenia Gravis Disease Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 India Myasthenia Gravis Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Myasthenia Gravis Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 India Myasthenia Gravis Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 India Myasthenia Gravis Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Myasthenia Gravis Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 India Myasthenia Gravis Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 India Myasthenia Gravis Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Myasthenia Gravis Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Myasthenia Gravis Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Myasthenia Gravis Disease Market Revenues & Volume, By Onlin Pharmacy, 2021- 2031F |
6.5.4 India Myasthenia Gravis Disease Market Revenues & Volume, By Retail Phrmacy, 2021- 2031F |
7 India Myasthenia Gravis Disease Market Import-Export Trade Statistics |
7.1 India Myasthenia Gravis Disease Market Export to Major Countries |
7.2 India Myasthenia Gravis Disease Market Imports from Major Countries |
8 India Myasthenia Gravis Disease Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for new myasthenia gravis treatments |
8.2 Number of healthcare facilities offering specialized care for myasthenia gravis patients |
8.3 Research and development investment in novel therapies for myasthenia gravis |
9 India Myasthenia Gravis Disease Market - Opportunity Assessment |
9.1 India Myasthenia Gravis Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 India Myasthenia Gravis Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 India Myasthenia Gravis Disease Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 India Myasthenia Gravis Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 India Myasthenia Gravis Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Myasthenia Gravis Disease Market - Competitive Landscape |
10.1 India Myasthenia Gravis Disease Market Revenue Share, By Companies, 2024 |
10.2 India Myasthenia Gravis Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here